Cite
MLA Citation
N Boku et al.. “Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4).” Annals of oncology, vol. 30, 2019, pp. 250–258. http://access.bl.uk/ark:/81055/vdc_100092358679.0x000039